A couple of weeks ago, I blogged about looking beyond the Vanguard MSCI Emerging Markets ETF (NYSEArca: VWO) and the iShares MSCI Emerging Markets Index Fund (NYSE Arca: EEM) for emerging markets exposure.
Specifically, I mentioned a few single-country ETFs with potential for outperformance in the coming decade.
But for investors uncomfortable with jumping into country-specific ETFs and who prefer broad exposure, dividend-weighted funds like the WisdomTree Emerging Markets Equity Income Fund (NYSEArca: DEM), can offer a great alternative way to play emerging markets.
DEM differs from cap-weighted funds like VWO and EEM by not only weighting its constituents by annual dividends paid, but also by selecting its holdings based on dividend yields.
And true to its word, DEM sports an impressive dividend yield.
It might come as a surprise to you that DEM actually has a trailing 12-month yield of 4.45 percent and a 30-day SEC yield of 3.21 percent. In comparison, VWO and EEM have a trailing 12-month yield of 2.36 and 2.12 percent, respectively.
DEM's dividend-based methodology also leads to a unique portfolio with very different country exposures than what investors get in VWO or EEM via the MSCI Emerging Markets Index.
|Country Weightings (in %)|
|EEM (MSCI EM Index)||DEM (WisdomTree
EM Equity Income Index)
Source: Issuer websites
But the real kicker here is that it's handily outperformed both VWO and EEM over one- and three-year periods in total returns—and in also in price returns.
Smart beta isn’t smarter than cap weighting, but it is different, and that’s great for investors.
Trial by fire is one way to discover why ETF transparency matters.
Most people now realize leveraged ETFs can hurt you, but how, then, to use them?
What would a shift out of a mutual fund and into an ETF look like up close?